Nevro Corp
NVRO
Market Cap$386.02M
Close$
$14.29
40.2% upside
Current Fair Value
40.2% upsideUndervalued by 40.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $386.02 Million |
|---|---|
| Enterprise Value | $319.30 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.28 |
| Beta | 1.75 |
| Outstanding Shares | 36,728,648 |
| Avg 30 Day Volume | 587,663 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.67 |
|---|---|
| PEG | 17.02 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 0.74 |
| Enterprise Value to EBIT | -3.35 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | 0.77 |
Revenue Sources
No data
ESG Score
No data
About Nevro Corp
CEO: D.Keith Grossman Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and c...